Page last updated: 2024-11-06

hydroxyproline and Carcinoma, Ductal, Pancreatic

hydroxyproline has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies

Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"Pancreatic cancer is notorious for its poor prognosis."1.43Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2. ( Cabral, H; Iwata, C; Kano, MR; Miyazono, K; Morishita, Y; Sakai, S; Tanaka, HY, 2016)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakai, S1
Iwata, C1
Tanaka, HY1
Cabral, H1
Morishita, Y1
Miyazono, K1
Kano, MR1

Other Studies

1 other study available for hydroxyproline and Carcinoma, Ductal, Pancreatic

ArticleYear
Increased fibrosis and impaired intratumoral accumulation of macromolecules in a murine model of pancreatic cancer co-administered with FGF-2.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, 05-28, Volume: 230

    Topics: Albumin-Bound Paclitaxel; Animals; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Cell Line, T

2016